ICL accelerates biologicals portfolio growth in Brazil with Nitro 1000 buy
ICL Stock | USD 4.58 0.02 0.44% |
About 55% of ICL Israel's institutional investors are presently thinking to get in. The analysis of overall sentiment of trading ICL Israel Chemicals stock suggests that some investors are interested at this time. ICL Israel's investing sentiment shows overall attitude of investors towards ICL Israel Chemicals.
ICL |
ICL acquires Nitro 1000, a Brazilian biologicals manufacturer, to expand its presence in new markets.
Read at seekingalpha.com
ICL Israel Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ICL Israel can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ICL Israel Fundamental Analysis
We analyze ICL Israel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
ICL Israel is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
ICL Israel Chemicals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICL Israel stock to make a market-neutral strategy. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics with similar companies.
Peers
ICL Israel Related Equities
UAN | CVR Partners | 7.69 | ||||
BHIL | Benson Hill, | 3.24 | ||||
MOS | Mosaic | 2.84 | ||||
BIOX | Bioceres Crop | 1.71 | ||||
NTR | Nutrien | 1.24 | ||||
CF | CF Industries | 1.13 | ||||
IPI | Intrepid Potash | 0.11 | ||||
CTA-PB | E I | 0.07 | ||||
AVD | American Vanguard | 0.33 | ||||
CTVA | Corteva | 0.42 | ||||
FMC | FMC | 0.69 |
Check out ICL Israel Hype Analysis, ICL Israel Correlation and ICL Israel Performance. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 0.2 | Earnings Share 0.31 | Revenue Per Share 5.373 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.